PUBLISHER: The Business Research Company | PRODUCT CODE: 1751098
PUBLISHER: The Business Research Company | PRODUCT CODE: 1751098
Retinal detachment is a medical condition in which the retina, the light-sensitive layer of tissue at the back of the eye, separates from its underlying supportive tissue. This separation interferes with the retina's normal function and can lead to vision loss or blindness if not addressed promptly.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The main types of retinal detachment include rhegmatogenous retinal detachment, tractional retinal detachment, and exudative retinal detachment. Rhegmatogenous retinal detachment occurs when a tear or hole in the retina allows fluid to seep through, causing the retina to detach from the underlying layers. This is the most common form of retinal detachment and is often associated with aging, eye injury, or severe nearsightedness. Treatment options for this condition include photocoagulation, cryopexy, pneumatic retinopexy, scleral buckling, and vitrectomy. These procedures are performed in hospitals, clinics, specialty centers, and other healthcare settings.
The retinal detachment market research report is one of a series of new reports from The Business Research Company that provides retinal detachment market statistics, including the retinal detachment global market size, regional shares, competitors with the retinal detachment market share, detailed retinal detachment market segments, market trends, and opportunities, and any further data you may need to thrive in the retinal detachment. This retinal detachment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The retinal detachment market size has grown strongly in recent years. It will grow from$2.16 billion in 2024 to $2.30 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historic period can be attributed to the aging population, a higher prevalence of diabetes, an increase in eye injuries, greater awareness of retinal diseases, and the expansion of healthcare infrastructure.
The retinal detachment market size is expected to see strong growth in the next few years. It will grow to$2.98 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth during the forecast period can be attributed to the rising cases of high myopia, greater adoption of minimally invasive procedures, improved access to specialized eye care, expanding health insurance coverage, and increasing research in gene therapy. Key trends anticipated in the forecast period include the development of artificial retina implants, the expansion of teleophthalmology services, advancements in stem cell therapy for retinal repair, the integration of robotic-assisted retinal surgeries, and improvements in retinal imaging.
The rising number of eye surgeries is expected to drive the growth of the retinal detachment market in the coming years. Eye surgeries are medical procedures performed to correct vision problems, treat eye diseases, or repair injuries. The increasing prevalence of eye surgeries is largely due to prolonged screen time, which leads to digital eye strain and worsens vision. This contributes to conditions such as cataracts and myopia, which often require surgical intervention. Additionally, lifestyle changes and the growing reliance on digital devices are increasing the incidence of eye-related issues. Retinal detachment, in particular, is driving advancements in eye surgeries by prompting the development of innovative techniques and technologies aimed at restoring vision, improving surgical precision, and enhancing patient outcomes. For example, in 2023, the Eye Bank Association of America reported a 2.7% increase in domestic keratoplasty procedures, rising from 49,597 in 2022 to 50,925 in 2023. Therefore, the growing number of eye surgeries is contributing to the expansion of the retinal detachment market.
Key players in the retinal detachment market are focusing on creating innovative services such as surgical retina programs to improve treatment outcomes and patient care. Surgical retina services are specialized medical programs or facilities offering advanced treatments for retinal conditions. These services focus on diagnosing and treating retinal disorders such as retinal detachment, macular holes, diabetic retinopathy, and age-related macular degeneration. For example, in July 2024, NYC Health + Hospitals/Harlem, a US-based teaching hospital, introduced a new Surgical Retina Service to enhance its ophthalmological capabilities in treating complex retinal conditions in the Harlem community. This service was developed in collaboration with Columbia University Irving Medical Center's Edward S. Harkness Eye Institute, which provided technical expertise. It aims to diagnose and treat various retinal diseases, including retinal detachment, which is one of the leading causes for retinal surgery.
In April 2022, Carl Zeiss Meditec AG, a medical technology company based in Germany, acquired Kogent Surgical LLC and Katalyst Surgical LLC for an undisclosed sum. This acquisition strengthens Carl Zeiss Meditec's position as a leading provider of ophthalmic and microsurgical solutions by integrating high-quality surgical instruments from both companies into its portfolio. The move expands its surgical offerings while enhancing recurring revenue streams. Kogent Surgical LLC is a US-based manufacturer of precision microsurgical instruments for neurosurgery and ophthalmology, while Katalyst Surgical LLC specializes in retinal detachment devices.
Major players in the retinal detachment market are Baxter International Inc., Alcon Vision LLC, Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Santen Pharmaceutical Co. Ltd., Optos plc, IRIDEX Corporation, Keeler Ltd. (A Halma Company), Rudolf Riester GmbH, Lombart Instrument Inc., Synergy Eye Care Pvt. Ltd., Ellex Medical Lasers Ltd., Millennium Surgical Corp., iCare World (iCare Finland Oy), Surtex Instruments Limited, Eyenuk Inc., Lumibird Medical, NIDEK Co. Ltd., ONL Therapeutics Inc., and FCI Ophthalmics.
North America was the largest region in the retinal detachment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in retinal detachment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the retinal detachment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The retinal detachment market consists of revenues earned by entities by providing medical services such as diagnosis, surgical treatments, and laser therapies for retinal detachment. The market value includes the value of related goods sold by the service provider or included within the service offering. The retinal detachment market also includes sales of diagnostic equipment, surgical instruments, vitrectomy machines, and anti-inflammatory and anti-VEGF drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Retinal Detachment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on retinal detachment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for retinal detachment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The retinal detachment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.